Van Tuyl Christopher sold IMVT
June 18, 2026 · Form 4 insider transaction
Van Tuyl Christopher sold 2,634 shares of Immunovant, Inc. at $35.39 per share, a transaction worth $93.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
On December 16, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on June 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.